Keywords: GlaxoSmithKline, Targacept, Termination, Alliance, Neuropathic pain,

GlaxoSmithKline pulls out of Targacept alliance

Article | 04 March 2011

North Carolina, USA-based Targacept (Nasdaq: TRGT) which is developing novel NNR Therapeutics, yesterday announced the termination of its strategic alliance ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Targacept

GlaxoSmithKline

Go to company listing